Cargando…
Comparison of outcomes between symptomatic and asymptomatic patients with colorectal cancer: a propensity score-matched analysis of surgical invasiveness, medical costs and oncological outcomes
BACKGROUND AND AIMS: Whether asymptomatic patients with colorectal cancer (CRC) who are treated in hospitals show better outcomes than symptomatic patients with CRC still remains unknown. The aim of this study was to evaluate differences in clinical benefits following treatment in asymptomatic and s...
Autores principales: | Inada, Ryo, Nagasaka, Takeshi, Watanabe, Ayako, Yagi, Tomohiko, Mori, Yoshiko, Kondo, Yoshitaka, Kishimoto, Hiroyuki, Umeda, Yuzo, Fujiwara, Toshiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609081/ https://www.ncbi.nlm.nih.gov/pubmed/28944068 http://dx.doi.org/10.1136/bmjgast-2017-000146 |
Ejemplares similares
-
The rare BRAF VK600-601E mutation as a possible indicator of poor prognosis in rectal carcinoma – a report of a case
por: Mori, Yoshiko, et al.
Publicado: (2015) -
2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World
por: van Gijn, W., et al.
Publicado: (2010) -
Primary Anastomosis Versus End-Ostomy in Left-Sided Colonic and Proximal Rectal Cancer Surgery in the Elderly Dutch Population: A Propensity Score Matched Analysis
por: van Loon, Yu Ting, et al.
Publicado: (2021) -
Systematic Review of Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer
por: McKigney, Niamh, et al.
Publicado: (2023) -
BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer
por: Morikawa, Tatsuya, et al.
Publicado: (2018)